Department of Neurology, Georgia Regents University, Augusta, GA.
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e671-3. doi: 10.1016/j.jstrokecerebrovasdis.2013.06.019. Epub 2013 Jul 5.
To describe a case of recanalization of a basilar artery occlusion with intravenous (IV) tenecteplase.
A 74-year-old man with a history of cardiomyopathy presented to an outside hospital with acute vertigo, dysarthria, gaze deviation, and ataxia. Computerized tomography arteriography demonstrated occlusion of the proximal basilar artery. IV tissue plasminogen activator was ordered; however, the patient received a cardiac dose of IV tenecteplase. The patient was transferred to our facility, whereby symptoms resolved, and repeat computerized tomography arteriography displayed recanalization of the basilar artery.
Tenecteplase has enhanced biochemical and pharmacokinetic properties that may be ideal for treatment of basilar artery occlusion and should be further investigated in a randomized clinical trial.
描述一例使用静脉(IV)替奈普酶再通基底动脉闭塞的病例。
一名 74 岁男性,有心肌病病史,因急性眩晕、构音障碍、眼球偏斜和共济失调到外院就诊。计算机断层血管造影显示近端基底动脉闭塞。IV 组织型纤溶酶原激活物已开处方;然而,患者接受了心脏剂量的 IV 替奈普酶。患者转至我院,症状缓解,重复计算机断层血管造影显示基底动脉再通。
替奈普酶具有增强的生化和药代动力学特性,可能是治疗基底动脉闭塞的理想选择,应在随机临床试验中进一步研究。